Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

No Clinical Benefit of Intramuscular Delivery of Bone Marrow-derived Mononuclear Cells in Nonreconstructable Peripheral Arterial Disease: Results of a Phase-III Randomized-controlled Trial.

Lindeman JHN, Zwaginga JJ, Kallenberg-Lantrua G, van Wissen RC, Schepers A, van Bockel HJ, Fibbe WE, Hamming JF.

Ann Surg. 2018 Jul 12. doi: 10.1097/SLA.0000000000002896. [Epub ahead of print]

PMID:
30004916
2.

Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.

Saris A, Peyron I, van der Meer PF, Stuge TB, Zwaginga JJ, van Ham SM, Ten Brinke A.

Front Immunol. 2018 Jun 5;9:1251. doi: 10.3389/fimmu.2018.01251. eCollection 2018.

3.

Short-term effect of preoperative intravenous iron therapy in colorectal cancer patients with anemia: results of a cohort study.

Wilson MJ, Dekker JW, Bruns E, Borstlap W, Jeekel J, Zwaginga JJ, Schipperus M.

Transfusion. 2018 Mar;58(3):795-803. doi: 10.1111/trf.14456. Epub 2017 Dec 17.

PMID:
29250797
4.

Platelets from donors with consistently low HLA-B8, -B12, or -B35 expression do not undergo antibody-mediated internalization.

Saris A, Tomson B, Brand A, Mulder A, Claas FH, Lorinser J, Scharenberg J, van Ham SM, Ten Brinke A, Zwaginga JJ, van der Meer PF.

Blood. 2018 Jan 4;131(1):144-152. doi: 10.1182/blood-2017-07-799270. Epub 2017 Nov 1.

PMID:
29092829
5.

Age of platelet concentrates and time to the next transfusion.

Caram-Deelder C, van der Bom JG, Putter H, Leyte A, Kerkhof DV, Evers D, Beckers EA, Weerkamp F, Hudig F, Zwaginga JJ, Rondeel JMM, de Vooght KMK, Péquériaux NCV, Visser O, Wallis JP, Middelburg RA.

Transfusion. 2018 Jan;58(1):121-131. doi: 10.1111/trf.14388. Epub 2017 Oct 31.

PMID:
29090466
6.

Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients.

Caram-Deelder C, Kreuger AL, Evers D, de Vooght KMK, van de Kerkhof D, Visser O, Péquériaux NCV, Hudig F, Zwaginga JJ, van der Bom JG, Middelburg RA.

JAMA. 2017 Oct 17;318(15):1471-1478. doi: 10.1001/jama.2017.14825. Erratum in: JAMA. 2018 Feb 20;319(7):724.

7.

An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study.

Zeller MP, Barty R, Dunbar NM, Elahie A, Flanagan P, Garritsen H, Kutner JM, Pagano MB, Pogłód R, Rogers TS, Staves J, van Wordragen-Vlaswinkel M, Zwaginga JJ, Murphy MF, Heddle NM, Yazer MH; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Transfusion. 2018 Jan;58(1):151-157. doi: 10.1111/trf.14368. Epub 2017 Oct 14.

PMID:
29030954
8.

Identification of underlying and transfusion-related platelet qualitative alterations in the hemato-oncologic patient.

Vicente-Ayuso C, Papadopoulos P, Villa-Fajardo M, Prieto B, Álvarez-Carmona AM, Mateo-Morales M, Pérez-López C, Peña-Cortijo A, Polo-Zarzuela M, Sáez I, Martín MP, Benavente-Cuesta C, González-Fernández A, Martínez-Martínez R, Zwaginga JJ, Seghatchian J, Gutiérrez L.

Transfus Apher Sci. 2017 Oct;56(5):756-768. doi: 10.1016/j.transci.2017.08.020. Epub 2017 Aug 31. Review.

PMID:
28970003
9.

An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study.

Zeller MP, Barty R, Aandahl A, Apelseth TO, Callum J, Dunbar NM, Elahie A, Garritsen H, Hancock H, Kutner JM, Manukian B, Mizuta S, Okuda M, Pagano MB, Pogłód R, Rushford K, Selleng K, Sørensen CH, Sprogøe U, Staves J, Weiland T, Wendel S, Wood EM, van de Watering L, van Wordragen-Vlaswinkel M, Ziman A, Jan Zwaginga J, Murphy MF, Heddle NM, Yazer MH; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Transfusion. 2017 Oct;57(10):2329-2337. doi: 10.1111/trf.14255. Epub 2017 Aug 25.

PMID:
28840943
10.

Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long-term results.

Rodrigo SF, Mann I, van Ramshorst J, Beeres SL, Zwaginga JJ, Fibbe WE, Bax JJ, Schalij MJ, Atsma DE.

J Interv Cardiol. 2017 Oct;30(5):440-447. doi: 10.1111/joic.12408. Epub 2017 Jul 28.

PMID:
28752630
11.

Storage time of platelet concentrates and all-cause bacteremia in hematologic patients.

Kreuger AL, Middelburg RA, Bank CMC, Beckers EAM, van Gammeren AJ, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, Kerkhoffs JLH, van der Bom JG.

Transfusion. 2017 Sep;57(9):2096-2103. doi: 10.1111/trf.14194. Epub 2017 Jun 26.

PMID:
28653425
12.

Impact of red blood cell transfusion strategies in haemato-oncological patients: a systematic review and meta-analysis.

Hoeks MPA, Kranenburg FJ, Middelburg RA, van Kraaij MGJ, Zwaginga JJ.

Br J Haematol. 2017 Jul;178(1):137-151. doi: 10.1111/bjh.14641. Epub 2017 Jun 7. Review.

PMID:
28589623
13.

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients.

Porcelijn L, Huiskes E, Schipperus M, van der Holt B, de Haas M, Zwaginga JJ; Dutch HOVON 64 Study Group.

Blood. 2017 Jun 22;129(25):3389-3391. doi: 10.1182/blood-2016-11-751719. Epub 2017 May 3. No abstract available.

14.

Absence of the spleen and the occurrence of primary red cell alloimmunization in humans.

Evers D, van der Bom JG, Tijmensen J, de Haas M, Middelburg RA, de Vooght KMK, van de Kerkhof D, Visser O, Péquériaux NCV, Hudig F, Zwaginga JJ.

Haematologica. 2017 Aug;102(8):e289-e292. doi: 10.3324/haematol.2016.162685. Epub 2017 Apr 14. No abstract available.

15.

Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.

van Oostrum A, Zwaginga JJ, Croockewit S, Overdevest J, Fechter M, Ruiterkamp B, Brand A, Netelenbos T.

J Clin Apher. 2017 Dec;32(6):397-404. doi: 10.1002/jca.21528. Epub 2017 Jan 31.

PMID:
28139098
16.

Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization.

Evers D, Zwaginga JJ, Tijmensen J, Middelburg RA, de Haas M, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, van der Bom JG.

Haematologica. 2017 Jan;102(1):52-59. doi: 10.3324/haematol.2016.152074. Epub 2016 Sep 15.

17.

Red cell alloimmunisation in patients with different types of infections.

Evers D, van der Bom JG, Tijmensen J, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, Zwaginga JJ.

Br J Haematol. 2016 Dec;175(5):956-966. doi: 10.1111/bjh.14307. Epub 2016 Aug 18.

PMID:
27539877
18.

Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.

Evers D, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, Schonewille H, Zwaginga JJ, van der Bom JG.

Lancet Haematol. 2016 Jun;3(6):e284-92. doi: 10.1016/S2352-3026(16)30019-9. Epub 2016 May 9.

PMID:
27264038
19.

Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk.

Middelburg RA, Carbaat-Ham JC, Hesam H, Ragusi MA, Zwaginga JJ.

Hematology. 2016 Oct;21(9):549-51. doi: 10.1080/10245332.2016.1180097. Epub 2016 May 9.

PMID:
27159138
20.

Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature.

Winkelhorst D, Kamphuis MM, de Kloet LC, Zwaginga JJ, Oepkes D, Lopriore E.

Transfusion. 2016 May;56(5):1230-5. doi: 10.1111/trf.13550. Epub 2016 Mar 20.

PMID:
26996515

Supplemental Content

Loading ...
Support Center